Transgenic animals as drug factories: a new source of recombinant protein therapeutics

Author： van Cott K.E.   Velander W.H.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.7, Iss.10, 1998-10, pp. : 1683-1690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Protein Based Therapeutics for IPF

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 2, 2013-04 ,pp. : 109-123

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Engineering: A New Frontier for Biological Therapeutics

By  

Current Drug Metabolism, Vol. 15, Iss. 7, 2014-01 ,pp. : 743-756

Bentham Science Publishers

Access to resources Recommend Favorite

APP Transgenic Mouse Models and their Use in Drug Discovery to Evaluate Amyloid-&bgr; Lowering Therapeutics

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-01 ,pp. : 395-402

Bentham Science Publishers

Access to resources Recommend Favorite

HPLC determination of the new cardiotropic drug protecor in blood serum of animals

By Ptitsina S.   Bobrov V.   Serov L.   Borisov M.   Ivanova I.   Miroshnichenko I.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 12, 2006-12 ,pp. : 683-685

Springer Publishing Company

Access to resources Recommend Favorite

Polymer therapeutics—polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities*

By Duncan Ruth   Ringsdorf Helmut   Satchi-Fainaro Ronit  

Journal of Drug Targeting, Vol. 14, Iss. 6, 2006-07 ,pp. : 337-341

Informa Healthcare

Access to resources Recommend Favorite